- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacokinetic evaluation of capecitabine in breast cancer
Authors
Keywords
-
Journal
Expert Opinion on Drug Metabolism & Toxicology
Volume 9, Issue 2, Pages 225-235
Publisher
Informa Healthcare
Online
2013-01-10
DOI
10.1517/17425255.2013.759939
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A multicenter randomized phase III trial of vinorelbine/gemcitabine doublet versus capecitabine monotherapy in anthracycline- and taxane-pretreated women with metastatic breast cancer
- (2011) A. G. Pallis et al. ANNALS OF ONCOLOGY
- Phase II trial of a novel capecitabine dosing schedule in combination with lapatinib for the treatment of patients with HER2-positive metastatic breast cancer
- (2011) Devika Gajria et al. BREAST CANCER RESEARCH AND TREATMENT
- Inhibition of EGFR phosphorylation in a panel of human breast cancer cells correlates with synergistic interactions between gefitinib and 5′-DFUR, the bioactive metabolite of Xeloda®
- (2011) Maria Ait-Tihyaty et al. BREAST CANCER RESEARCH AND TREATMENT
- Phase 2 trial of a novel capecitabine dosing schedule in combination with bevacizumab for patients with metastatic breast cancer
- (2011) Devika Gajria et al. CANCER
- Capecitabine Versus Classical Cyclophosphamide, Methotrexate, and Fluorouracil As First-Line Chemotherapy for Advanced Breast Cancer
- (2011) Martin R. Stockler et al. JOURNAL OF CLINICAL ONCOLOGY
- RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative, Locally Recurrent or Metastatic Breast Cancer
- (2011) Nicholas J. Robert et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparison of in vitro metabolic conversion of capecitabine to 5-FU in rats, mice, monkeys and humans - toxicological implications
- (2011) Hidetoshi Shindoh et al. JOURNAL OF TOXICOLOGICAL SCIENCES
- Analysis of overall survival from a phase III study of ixabepilone plus capecitabine versus capecitabine in patients with MBC resistant to anthracyclines and taxanes
- (2010) Gabriel N. Hortobagyi et al. BREAST CANCER RESEARCH AND TREATMENT
- Vorinostat synergises with capecitabine through upregulation of thymidine phosphorylase
- (2010) E Di Gennaro et al. BRITISH JOURNAL OF CANCER
- First-line chemotherapy for metastatic breast cancer in patients ≥75 years: A retrospective single-centre analysis
- (2010) Marc Debled et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- First-line therapy with moderate dose capecitabine in metastatic breast cancer is safe and active: Results of the MONICA trial
- (2010) M. Kaufmann et al. EUROPEAN JOURNAL OF CANCER
- Target-based therapies in breast cancer: current status and future perspectives
- (2009) Nicola Normanno et al. ENDOCRINE-RELATED CANCER
- Trastuzumab Beyond Progression in Human Epidermal Growth Factor Receptor 2–Positive Advanced Breast Cancer: A German Breast Group 26/Breast International Group 03-05 Study
- (2009) Gunter von Minckwitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase II Trial of First-Line Trastuzumab Plus Docetaxel and Capecitabine Compared With Trastuzumab Plus Docetaxel inHER2-Positive Metastatic Breast Cancer
- (2009) Andrew M. Wardley et al. JOURNAL OF CLINICAL ONCOLOGY
- Thymidine phosphorylase expression is associated with time to progression in patients receiving low-dose, docetaxel-modulated capecitabine for metastatic breast cancer
- (2008) F. Puglisi et al. ANNALS OF ONCOLOGY
- Thymidine phosphorylase expression and benefit from capecitabine in patients with advanced breast cancer
- (2008) C. Andreetta et al. ANNALS OF ONCOLOGY
- A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses
- (2008) David Cameron et al. BREAST CANCER RESEARCH AND TREATMENT
- Phase I Study of a Novel Capecitabine Schedule Based on the Norton-Simon Mathematical Model in Patients With Metastatic Breast Cancer
- (2008) Tiffany A. Traina et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started